Pharma News

FTC Files Lawsuit to Prevent IQUVIA Propel Media Purchase

In a move to block a full takeover of Propel Media, the Federal Trade Commission (FTC) has announced its intentions to sue IQUVIA. As part of the lawsuit, the agency alleges that the proposed acquisition would give IQVIA a market- leading position in programmatic advertising for health care products. They also claim the merger would create a monopoly by withholding key information from competitors.

“Protecting competition in the emerging health care programmatic advertising market plays a critical role in lowering health care costs, including the cost of prescription drugs,” said Holly Vedova, bureau of competition director, FTC. “Given the rampant consolidation across the pharmaceutical industry, it’s critical that the market for health care product advertising remains competitive to ensure that patients and their doctors have access to high quality, affordable products.”

Reference: FTC Sues to Block IQVIA’s Acquisition of Propel Media to Prevent Increased Concentration in Health Care Programmatic Advertising. FTC. July 17, 2023. Accessed July 18, 2023. https://www.ftc.gov/news-events/news/press-releases/2023/07/ftc-sues-block-iqvias-acquisition-propel-media-prevent-increased-concentration-health-care

Source link
#FTC #Files #Lawsuit #Prevent #IQUVIA #Propel #Media #Purchase

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *